the patients who received placebo only lost 2.4% of their excess body weight a 12.5% difference in lost body weight between treated and non-treated patients Semaglutide weight loss mechanism #2: it controls appetite and promotes satiety Semaglutide limits appetite and promotes feelings of satiety (fullness): Peripherally administered GLP-1 also affects the central regulation of feeding
People might move from having a burger for lunch everyday to realizing that now that theyre on Zepbound, they cant do or dont want to do that
And, if youre comfortable at a certain dose and getting the desired results, theres no reason to move to the next dose
Residual beta-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes
These therapies, already well-known in diabetes treatment, are now acknowledged as effective weight-loss tools when combined with behavior modification and health monitoring
The encouraging part is that 2026 introduced more flexible optionslike lower-cost oral versions, cash-pay programs, and pilot insurance coveragethat can bring costs down meaningfully if you know where to look